8 results match your criteria: "Academic Teaching Hospital of the University of Muenster[Affiliation]"
BMC Geriatr
April 2024
Department of Geriatrics & Neurology, Johanniter Hospital Bonn, Johanniter Strasse 1-3, Bonn, 53113, Germany.
Background: The Comprehensive Geriatric Assessment (CGA) records geriatric syndromes in a standardized manner, allowing individualized treatment tailored to the patient's needs and resources. Its use has shown a beneficial effect on the functional outcome and survival of geriatric patients. A recently published German S1 guideline for level 2 CGA provides recommendations for the use of a broad variety of different assessment instruments for each geriatric syndrome.
View Article and Find Full Text PDFLancet Neurol
April 2024
Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck - Academic teaching hospital of the University of Muenster, Osnabrueck, Lower Saxony, Germany.
Cancers (Basel)
April 2023
Department of Palliative Care, University Hospital Muenster, 48149 Muenster, Germany.
(1) Background: As the number of people receiving specialized palliative care (PC) continues to rise, there is a need to ensure the transfer of this expertise from university-based PC departments to primary care hospitals without such in-house access. The present study examines the potential of telemedicine to bridge these gaps. (2) Methods: This is a prospective multi-center feasibility trial.
View Article and Find Full Text PDFDermatol Ther (Heidelb)
October 2020
Department of Dermatology and Allergology, Municipal Hospital of Bielefeld, Academic Teaching Hospital of the University of Muenster, Bielefeld, Germany.
Folliculotropic mycosis fungoides (FMF) is a particular subtype of mycosis fungoides (MF), characterized by an infiltration of neoplastic CD4+ T cells in the epidermis which can spread to all follicular structures, sebaceous glands, sweat glands and hair follicles. Clinically, FMF can exhibit various cutaneous symptoms. However, these symptoms often occur on the scalp, face and neck, which are rarely affected by conventional MF.
View Article and Find Full Text PDFClin Res Cardiol
May 2006
Department of Cardiology and Internal Intensive Medicine, The Bielefeld Community Hospital, Academic Teaching Hospital of the University of Muenster, Bielefeld, Germany.
Background: Relatively few reports on the clinical impact of atrial fibrillation (AF) in hypertrophic obstructive cardiomyopathy (HOCM) are available. The aims of our study are to report the effect of transcoronary ablation of septal hypertrophy (TASH) on clinical outcome in HOCM associated with AF and to evaluate the influence of AF on symptoms and quality of life in HOCM.
Patient And Methods: In 80 consecutive patients (38 f, mean age 56 +/- 17 years) with severely symptomatic HOCM referred for interventional treatment, we analyzed the prevalence of AF based on 240 Holter ECG recordings and patients' history, retrospectively.
Pacing Clin Electrophysiol
April 2005
Department of Cardiology and Internal Intensive Care, Bielefeld Klinikum, Academic Teaching Hospital of the University of Muenster, Teutoburger Strasse 50, D-33604 Bielefeld, Germany.
Introduction: Transcoronary ablation of septal hypertrophy (TASH) is safe and effectively reduces the intraventricular gradient in patients with hypertrophic obstructive cardiomyopathy (HOCM). To analyze the potential of anti- and proarrhythmic effects of TASH, we studied the discharge rates of implanted cardioverter defibrillators (ICD) in patients with HOCM who are at a high risk for sudden cardiac death.
Methods: ICD and TASH were performed in 15 patients.
Heart
June 2004
Department of Cardiology and Internal Intensive Care, Bielefeld Clinicum, Academic Teaching Hospital of the University of Muenster, Bielefeld, Germany.
Objective: To evaluate symptomatic and haemodynamic results of transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy in elderly patients.
Setting: Tertiary referral centre for patients with hypertrophic obstructive cardiomyopathy.
Design: Retrospective study of two groups of consecutive patients divided at a median age (59 years).
Circulation
July 2002
Department of Internal Medicine and Cardiology, The Bielefeld Hospital, Academic Teaching Hospital of the University of Muenster, Bielefeld, Germany.
Background: Transcoronary ablation of septal hypertrophy (TASH) for hypertrophic cardiomyopathy seems to be an effective alternative to surgical myectomy. It remains a point of debate whether an outflow obstruction at rest is a necessary criterion for interventional therapy.
Methods And Results: TASH was compared in 45 consecutive patients with no resting gradient and a provocable gradient of > or =30 mm Hg (group I) and in 84 consecutive patients with a resting gradient of > or =30 mm Hg (80+/-33 mm Hg) (group II).